The U.K. is establishing a new biosecurity center designed to improve research into potentially pandemic-causing pathogens ...

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

Japanese drug major Astellas Pharma has signed a memorandum of understanding with the Korea Institute of Startup and ...

Top regulators like the US FDA and EMA are fast-tracking more Chinese drugs, granting priority review and breakthrough ...

Discover how Genome Valley is emerging as an essential partner in global biopharma and how it is now venturing into cell and ...

As one FDA initiative works to sustain the momentum of rare disease research, other events threaten to slow progress.

The new space is a free community service meant to help healthcare entrepreneurs connect with potential funders.

Partnership established to develop and scale production of ATL-105, a novel recombinant version of alpha-1 antitrypsin Lead ...

CSHL and Skanska top out a $248M AI and biology center, boosting neuroscience, cancer and AI research with major support from New York State.

David A. Schooley, Ph.D., a distinguished professor emeritus of biochemistry, a renowned insect endocrinologist, and a ...

The first step in the project was taken in November 2024, when the Chinese branch of the Belarus-China center for basic ...